ANALYSIS OF GALANIN AND THE GALANIN ANTAGONIST M40 ON DELAYED NON-MATCHING-TO-POSITION PERFORMANCE IN RATS LESIONED WITH THE CHOLINERGIC IMMUNOTOXIN (192)IGG-SAPORIN
Mp. Mcdonald et al., ANALYSIS OF GALANIN AND THE GALANIN ANTAGONIST M40 ON DELAYED NON-MATCHING-TO-POSITION PERFORMANCE IN RATS LESIONED WITH THE CHOLINERGIC IMMUNOTOXIN (192)IGG-SAPORIN, Behavioral neuroscience, 111(3), 1997, pp. 552-563
Galanin is a 29-amino-acid neuropeptide that is overexpressed in Alzhe
imer's disease (AD) and impairs performance on rodent learning and mem
ory tasks. M40, a peptidergic galanin receptor ligand, blocks galanin-
induced impairments on delayed non-matching-to-position (DNMTP). The p
resent experiments used the (192)IgG-saporin lesion model of AD to eva
luate the actions of galanin and M40 on DNMTP when cholinergic transmi
ssion was reduced. Hippocampal choline acetyltransferase levels were c
orrelated with DNMTP choice accuracy in lesioned rats. Intracerebroven
tricular (icy) galanin reduced choice accuracy in both the lesioned an
d sham groups. M40 alone, either icy or intrahippocampal, did not affe
ct-choice accuracy in either group. These results suggest that excess
galanin can produce further deficits in DNMTP performance in a lesion
model of AD, but blocking endogenous galanin is not sufficient alone t
o improve performance in lesioned rats.